Insider · CIK 0001634189
Robert James Wills
Files at MIST (Milestone Pharmaceuticals Inc.), ACOG (Alpha Cognition Inc.). First filing Aug 21, 2025, latest Aug 24, 2026.
In brief
Robert James Wills files SEC Form 4 as director at ACOG (Alpha Cognition Inc.), and also at MIST (Milestone Pharmaceuticals Inc.). Since Aug 21, 2025, Robert James Wills has reported 2 open-market buys worth $224k and 0 open-market sells worth $0, the latest filed on Aug 24, 2026.
A track record needs three past buys with six months of prices behind them; Robert James Wills has 1, so none is measured yet.
The newest scored trade: bought $96k of ACOG on Aug 21, 2026, filed Aug 24, 2026, scored 31 (weak). In the last 12 months: 1 buy worth $96k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ACOG: Alpha Cognition Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | ACOGbuy Alpha Cognition Inc. | $96k 10,000 shares | +45% | +117% from low-1% from high | |
| 46Moderate | Alpha Cognition Inc. | $127k 15,000 shares | - | +125% from low-25% from high |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | ACOG Alpha Cognition Inc. | POpen-market purchase Common Shares | +10,000 | $9.62 | $96k | 32,241 | Aug 24, 2026 |
| Jun 10, 2026 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Stock Option (right to buy)derivative | +77,000 | $0.00 | $0 | 77,000 | Jun 12, 2026 |
| Jan 14, 2026 | ACOG Alpha Cognition Inc. | AGrant or award Common Shares | +7,241 | $0.00 | $0 | 22,241 | Jan 16, 2026 |
| Jan 14, 2026 | ACOG Alpha Cognition Inc. | AGrant or award Common Share Optionsderivative | +8,437 | $0.00 | $0 | 8,437 | Jan 16, 2026 |
| Aug 18, 2025 | ACOG Alpha Cognition Inc. | POpen-market purchase Common Stock | +15,000 | $8.49 | $127k | 15,000 | Aug 21, 2025 |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Common Shares | +50,000 | - | - | 65,000 | Jul 15, 2025 |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Series A Common Warrants (right to buy)derivative | +50,000 | - | - | 50,000 | Jul 15, 2025 |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Series B Common Warrants (right to buy)derivative | +50,000 | - | - | 50,000 | Jul 15, 2025 |
| Jun 10, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 12, 2025 |
| Apr 7, 2025 | ACOG Alpha Cognition Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +30,019 | $0.00 | $0 | 30,019 | Apr 9, 2025 |
Questions about Robert James Wills
Answered from the filings on this page, as of the latest one.
Is Robert James Wills buying or selling?
In the last 12 months Robert James Wills reported 1 open-market buy worth $96k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $96k of ACOG on Aug 21, 2026. Grants, option exercises and tax withholding are not counted.
How did Robert James Wills's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert James Wills has 1.
Where does Robert James Wills file Form 4?
Robert James Wills has filed Form 4 at ACOG (Alpha Cognition Inc.); MIST (Milestone Pharmaceuticals Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.